Tokushima University / Educator and Researcher Directory --- Yamada, Naoki

Search:

Research

Field of Study

Subject of Study

Book / Paper

Academic Paper (Judged Full Paper):

1.	Toshiaki Onitsuka, Tsuyoshi Okada, Naomi Hasegawa, Takashi Tsuboi, Junichi Iga, Norio Yasui-Furukori, Naoki Yamada, Hikaru Hori, Hiroyuki Muraoka, Kazutaka Ohi, Kazuyoshi Ogasawara, Shinichiro Ochi, Masahiro Takeshima, Kayo Ichihashi, Kentaro Fukumoto, Hitoshi Iida, Hisashi Yamada, Ryuji Furihata, Manabu Makinodan, Yoshikazu Takaesu, Shusuke Numata, Hiroshi Komatsu, Akitoyo Hishimoto, Mikio Kido, Kiyokazu Atake, Hirotaka Yamagata, Saya Kikuchi, Naoki Hashimoto, Masahide Usami, Eiichi Katsumoto, Takeshi Asami, Chika Kubota, Junya Matsumoto, Kenichiro Miura, Yoji Hirano, Koichiro Watanabe, Ken Inada and Ryota Hashimoto : Combination Psychotropic Use for Schizophrenia With Long-Acting Injectable Antipsychotics and Oral Antipsychotics: A Nationwide Real-World Study in Japan., Journal of Clinical Psychopharmacology, Vol.43, No.4, 365-368, 2023. (Summary) Presenting these real-world clinical results, we want to encourage clinicians to keep monotherapy in mind for the treatment of schizophrenia, especially by reducing concomitant use of antipsychotics in the LAI group and reducing hypnotic and/or antianxiety medication in the non-LAI group. (Keyword) Humans / Antipsychotic Agents / schizophrenia / Japan / Injections / Administration, Oral / Hypnotics and Sedatives / Delayed-Action Preparations (Link to Publication Site) ● Publication site (DOI): 10.1097/JCP.0000000000001704 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37216369 ● Search Scopus @ Elsevier (PMID): 37216369 ● Search Scopus @ Elsevier (DOI): 10.1097/JCP.0000000000001704 (DOI: 10.1097/JCP.0000000000001704, PubMed: 37216369)
2.	Hidehiro Umehara, Tomoya Takeda, Leona Yoshida, Kanae Matsuura, Mika Okumura-Fujita, Ryuta Tominaga, Yasuko Abe, Tarishi Masuda, Naoki Yamada and Shusuke Numata : Effects of group therapy on jumping to conclusion bias in adolescents with autism spectrum disorder: An exploratory study., The Journal of Medical Investigation : JMI, Vol.70, No.1.2, 115-122, 2023. (Summary) Jumping to conclusion (JTC)-a cognitive bias in thinking processes-leads to drawing conclusions based on little information, and could be related to psychosis and paranoia. While it has recently been pointed out that it could accompany the autism spectrum disorder (ASD), no interventions targeting this bias in adolescents with ASD have been reported. Therefore, this exploratory study investigated the effects of a group social cognition program on JTC bias in adolescents with ASD. Group rehabilitation using social cognition and interaction training (SCIT) was conducted for 12- to 18-year-old adolescents with ASD. An SCIT program comprehensively targets social cognitive functions, including interventions for JTC bias, and examines changes before and after the SCIT intervention, social cognitive functioning tasks, and subjective quality of life (QOL). Thirteen adolescents with ASD participated in this program ; 10 (76.9%) stayed through it. The proportion of participants with JTC bias decreased significantly before and after SCIT (before : 7/10 ; after : 1/10 ; p = 0.041), and subjective QOL increased significantly (p=0.014). The results show that a group social cognition program with a JTC bias approach improves the JTC bias and increases subjective QOL in adolescents with ASD. J. Med. Invest. 70 : 115-122, February, 2023. (Keyword) Humans / Adolescent / Child / Quality of Life / Autism Spectrum Disorder / Cognition / Psychotherapy, Group (Tokushima University Institutional Repository) ● Metadata: 118333 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.70.115 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 37164706 ● Summary page in Scopus @ Elsevier: 2-s2.0-85158825245 (Tokushima University Institutional Repository: 118333, DOI: 10.2152/jmi.70.115, PubMed: 37164706, Elsevier: Scopus)
3.	Naoki Yamada, Yoshihiro Nakadoi, Ryosuke Fukuma and Tetsuro Ohmori : Two children exhibiting social withdrawal, school refusal, and underlying generalized anxiety disorder successfully treated using a selective serotonin reuptake inhibitor., The Journal of Medical Investigation : JMI, Vol.67, No.3.4, 355-357, 2020. (Summary) Generalized anxiety disorder (GAD) sometimes exists in the background of social withdrawal and school refusal. Although clinical evidence suggests that selective serotonin reuptake inhibitors (SSRIs) are an effective treatment for GAD, they are not officially approved for GAD in Japan. In addition, it has been established that the use of SSRIs increases the risk for suicide and activation syndrome among young individuals. As such, there is currently little domestic clinical experience in prescribing SSRIs to young patients with GAD. The authors report two cases involving 10-year-old patients with GAD who were treated successfully with escitalopram and experienced subsequent improvement in social withdrawal and school refusal. One patient had autistic spectrum disorder and exhibited self-harm associated with anxiety symptoms, requiring careful use of SSRIs under hospitalization. The other patient was treated at an outpatient clinic without any side effects. In each case, improvement of anxiety symptoms with the use of SSRIs facilitated the introduction of psychoeducation and psychotherapy. It is important to accurately diagnose GAD, which may exist in the background of patients exhibiting social withdrawal and school refusal, and to treat the disorder appropriately. J. Med. Invest. 67 : 355-357, August, 2020. (Tokushima University Institutional Repository) ● Metadata: 115453 (Link to Publication Site) ● Publication site (DOI): 10.2152/jmi.67.355 (Link to Search Site for Scientific Articles) ● PubMed @ National Institutes of Health, US National Library of Medicine (PMID): 33148915 ● Search Scopus @ Elsevier (PMID): 33148915 ● Search Scopus @ Elsevier (DOI): 10.2152/jmi.67.355 (Tokushima University Institutional Repository: 115453, DOI: 10.2152/jmi.67.355, PubMed: 33148915)

Review, Commentary:

1.	Saaya Yamada, Hidehiro Umehara, Naoki Yamada and Hiroshi Nakayama : 英国で閉鎖に至ったGender Identity Development Service(GIDS)の事例から考える日本における性別違和への取り組みの展望, GID(性同一性障害)学会雑誌, Vol.16, 65-72, 2024.
2.	Tomohiko Nakayama, Yukiko Tomioka, Naoki Yamada, Hidehiro Umehara, Makoto Kinoshita, Masahito Nakataki and Shusuke Numata : 臨床現場におけるたとえ話, Japanese Journal of Psychiatric Treatment, Vol.37, No.7, 745-749, Jul. 2022. (Link to Search Site for Scientific Articles) ● CiNii @ National Institute of Informatics (CRID): 1520856045142110592 (CiNii: 1520856045142110592)

Proceeding of International Conference:

1.	Hidehiro Umehara, Tomoya Takeda, Matsuura Kanae, Abe Yasuko, Masuda Tarishi, Naoki Yamada and Shusuke Numata : Effectiveness of the group social cognition program on jumping to conclusion bias in adolescents with autism spectrum disorder., The 11th ASCAPAP, Kyoto, May 2023.

Proceeding of Domestic Conference:

1.	Saaya Yamada, Hidehiro Umehara, Naoki Yamada and 中山浩 : タヴィストッククリニックのGender Identity Development Service(GIDS)が閉鎖に至った経緯とその背景, GID(性同一性障害)学会第25回研究大会・総会, Mar. 2024.
2.	Yui Matsumoto, Masahito Nakataki, 石本良祐, 一宮俊文, 野田尚吾, 前田拓也, 増田太利志, Tomohiro Yoshida, Shun Aoi, Naoki Yamada, Yukiko Tomioka, Hidehiro Umehara, 土師正太郎, Koji Fujita, Yuishin Izumi and Shusuke Numata : ADの灰白質体積と神経心理検査および髄液アミロイドβの関連性の検討, 【第42回日本認知症学会学術総会, Nov. 2023.
3.	Tomohiko Nakayama, Yui Matsumoto, Yukiko Tomioka, Naoki Yamada, Masahito Nakataki and Shusuke Numata : 長期間維持電気けいれん療法を施行している遅発緊張病の一例, 第36回日本総合病院精神医学会総会, Nov. 2023.
4.	塩田恭史, Tomohiko Nakayama, Naoki Yamada, Masahito Nakataki and Shusuke Numata : 脳梗塞と転換症状の鑑別を要したうつ病の一例, 第63回中国・四国精神神経学会, Nov. 2023.
5.	大西将統, Yui Matsumoto, Naoki Yamada, Masahito Nakataki and Shusuke Numata : 入院治療が奏功した思春期の神経性無食欲症の1例, 第63回中国・四国精神神経学会, Nov. 2023.
6.	青山理央, Yui Matsumoto, Naoki Yamada, Masahito Nakataki and Shusuke Numata : パーキンソン病に対するDBS治療中に生じた希死念慮から自殺企図に至った一例, 第63回中国・四国精神神経学会, Nov. 2023.
7.	Yui Matsumoto, Masahito Nakataki, 石本良祐, 一宮俊文, 野田尚吾, 前田拓也, 増田太利志, Tomohiro Yoshida, Shun Aoi, Naoki Yamada, Yukiko Tomioka, Hidehiro Umehara, 土師正太郎, Koji Fujita, Yuishin Izumi and Shusuke Numata : 認知症の灰白質体積と神経心理検査および髄液アミロイドβの関連性の検討, 第45回日本生物学的精神医学会年会, Nov. 2023.
8.	松浦可苗, Hidehiro Umehara, Tomoya Takeda, 中村公哉, Naoki Yamada, 冨永隆太, 阿部恭子, 入澤航史, Kohei Matsumoto and Shusuke Numata : 年齢の影響を統制したASD傾向とヒント課題の関連, 第87回大会日本心理学会, Sep. 2023.
9.	鬼塚俊明, 岡田剛史, 長谷川尚美, 坪井貴嗣, Junichi Iga, 古郡規雄, Naoki Yamada, 堀輝, 村岡寛之, 大井一高, 小笠原一能, 越智紳一郎, 竹島正浩, 市橋香代, 福本健太郎, 飯田仁志, 山田恒, 降籏隆二, 牧之段学, 高江洲義和, Shusuke Numata, 小松浩, 菱本明豊, 木戸幹雄, 阿竹聖和, 山形弘隆, 菊地紗耶, 橋本直樹, 宇佐美政英, 勝元榮一, 浅見剛, 久保田智香, 松本純弥, 三浦健一郎, 平野羊嗣, 渡邊衡一郎, 稲田健 and 橋本亮太 : 持続性抗精神病注射薬剤(LAI)と経口抗精神病薬の併用薬の状況:日本における実態調査, 第119回日本精神神経学会学術総会, Jun. 2023.
10.	鬼塚俊明, 岡田剛史, 長谷川尚美, 坪井貴嗣, Junichi Iga, 古郡規雄, Naoki Yamada, 堀輝, 村岡寛之, 大井一高, 小笠原一能, 越智紳一郎, 竹島正浩, 市橋香代, 福本健太郎, 飯田仁志, 山田恒, 降籏隆二, 牧之段学, 高江洲義和, Shusuke Numata, 小松浩, 菱本明豊, 木戸幹雄, 阿竹聖和, 山形弘隆, 菊地紗耶, 橋本直樹, 宇佐美政英, 勝元榮一, 浅見剛, 久保田智香, 松本純弥, 三浦健一郎, 平野羊嗣, 渡邊衡一郎, 稲田健 and 橋本亮太 : 持続性抗精神病注射薬剤(LAI)と経口抗精神病薬の併用薬の状況:日本における実態調査, 第17回日本統合失調症学会, Mar. 2023.
11.	Masahito Nakataki, Naoki Yamada, 原田紗希 and Shusuke Numata : 希死念慮が急性期ACP(Advance Care Planning)に影響した一症例, 第35回日本総合病院精神医学会総会, Oct. 2022.
12.	Hidehiro Umehara, 中村公哉, Tomoya Takeda and Naoki Yamada : 青年期自閉スペクトラム症の社会性の障害とヒント課題の関連, 第62回日本児童青年精神医学会, Nov. 2021.
13.	中村公哉, Hidehiro Umehara, Tomoya Takeda and Naoki Yamada : 精神疾患を抱える子ども達の不登校の背景にある要因, 第62回日本児童青年精神医学会, Nov. 2021.

Products:

1.	Naoki Yamada : 不登校のこどもたちとその関わり, めんたる・へるす, Vol.69, 12-17, 2020.

Et cetera, Workshop:

1.	Hidehiro Umehara, Tomoya Takeda, Naoki Yamada, 中村公哉, 松浦可苗, 冨永隆太 and 阿部恭子 : ヒント課題を用いた中高生における心の理論の評価, 第20回精神疾患と認知機能研究会, Feb. 2022.

Grants-in-Aid for Scientific Research (KAKEN Grants Database @ NII.ac.jp)

Search by Researcher Number (00896590)